OMLONTI

Santen Pharmaceutical Co., Ltd.

Application Filed: 2017-11-13
Trademark Application Details
Trademark Logo OMLONTI
700
Live/Registered
REGISTERED
Research OneLook Acronym Finder
Serial Number79227958
Registration Number5640040
Mark Drawing Code4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Attorney NameJohn E. Lyhus
Attorney Docket Number8156-143815
Law Office AssignedN10
Employee NameCORWIN, CHARLOTTE K

Timeline

2017-11-13Application Filed
2018-10-16Published for Opposition
2019-01-01Location: PUBLICATION AND ISSUE SECTION
2019-01-01Status: Live/Registered
2019-01-01Trademark Registered
2019-01-01Transaction Date

Trademark Applicants & Owners

Owner: Santen Pharmaceutical Co., Ltd.
Address9-19, Shimoshinjo 3-chome, Higashiyodogawa-ku Osaka-shi, 533-8651Osaka-fu JP
Legal Entity TypeCorporation
Legal Entity State JP

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

John E. Lyhus
FITCH, EVEN, TABIN & FLANNERY LLP
120 S. LaSalle Street
Suite 2100
Chicago, IL, 60603

Good, Services, and Codes

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051Collyrium; eye drops; ophthalmological preparations; pharmaceutical preparations for treatment of cataracts; pharmaceutical preparations for treatment of glaucoma; pharmaceutical preparations for treatment of ocular hypertension; ophthalmic ointments for the treatment of eye diseases and conditions; pharmaceutical preparations for use in eye injections for the treatment of eye diseases and conditions; pharmaceutical preparations for treatment of pinguecula; pharmaceutical preparations for treatment of chalazion; pharmaceutical preparations for treatment of uveitis; eye drops for treatment of keratoconjunctival epithelial disorder; antibacterial eye drops; antiallergic eye drops; pharmaceutical preparations for the treatment of eye diseases and conditions; reagent paper for medical purposes; oiled paper for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; gauze for medical use; capsules for medicines, namely, capsules sold empty for pharmaceuticals and drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; eyepatches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton, namely, cotton for medical purposes, cotton sticks for medical purposes and antiseptic cotton; adhesive plasters, namely, adhesive plasters for medical purposes, sticking plasters for medical purposes and medical and surgical plasters; bandages for dressings; liquid bandages, namely, antiseptic liquid bandages, liquid bandage sprays and liquid bandages for skin wounds; breast-nursing pads; cotton sticks for medical purposes; incontinence diapers; diapers; diaper covers, namely, inserts specially adapted for cloth infant diapers made of microfiber and infant diaper covers of textile; dietary supplements for humans; nutritional supplements; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; beverages for babies, namely, infant formula and meal replacement beverages for babies adapted for medical use; food for babies; dietary supplements for animals

Trademark Filing History

DescriptionDateEvent Coding
SN ASSIGNED FOR SECT 66A APPL FROM IB2018-03-011 REPR M:
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2018-03-062 NWOS I:Incoming Correspondence
ASSIGNED TO EXAMINER2018-03-063 DOCK D:Assigned to Examiner
APPLICATION FILING RECEIPT MAILED2018-03-104 MAFR O:Outgoing Correspondence
NON-FINAL ACTION WRITTEN2018-03-135 CNRT R:Renewal
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW2018-03-146 RFCR E:E-Mail
REFUSAL PROCESSED BY MPU2018-03-207 RFRR P:
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB2018-03-208 RFCS P:
REFUSAL PROCESSED BY IB2018-04-069 RFNP P:
TEAS RESPONSE TO OFFICE ACTION RECEIVED2018-08-1510 TROA I:Incoming Correspondence
ASSIGNED TO LIE2018-08-3011 ALIE A:Allowance for Publication
CORRESPONDENCE RECEIVED IN LAW OFFICE2018-09-0612 CRFA I:Incoming Correspondence
TEAS/EMAIL CORRESPONDENCE ENTERED2018-09-0613 TEME I:Incoming Correspondence
APPROVED FOR PUB - PRINCIPAL REGISTER2018-09-1014 CNSA O:Outgoing Correspondence
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB2018-09-2615 OP2R P:
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2018-09-2616 NONP E:E-Mail
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB2018-09-2617 OPNS P:
NOTIFICATION PROCESSED BY IB2018-10-1218 GPNX P:
PUBLISHED FOR OPPOSITION2018-10-1619 PUBO A:Allowance for Publication
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2018-10-1620 NPUB E:E-Mail
REGISTERED-PRINCIPAL REGISTER2019-01-0121 R.PR A:Allowance for Publication
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB2019-04-0122 FICR P:
FINAL DISPOSITION PROCESSED2019-04-1723 FIMP P:
FINAL DISPOSITION NOTICE SENT TO IB2019-04-1724 FICS P:
FINAL DECISION TRANSACTION PROCESSED BY IB2019-05-0325 FINO P:
CHANGE OF NAME/ADDRESS REC'D FROM IB2020-05-0126 ADCH M:
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED2024-01-0127 REM3 E:E-Mail

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed